newsfilter
← Latest News
Business Wire·

Humanigen Announces Revised Time for Presentation at Jefferies London Healthcare Conference

Humanigen, Inc. (NASDAQ:HGEN) ("Humanigen"), a clinical-stage biopharmaceutical company focused on preventing and treating an immune hyper-response called ‘cytokine storm,' announced that its presentation time at the Jefferies London Healthcare Confer